| |
|

July 2018 Vol. 6 No.7
Other viewing option
Abstract
• Full text
•Reprint (PDF) (242 KB)
Search Pubmed for articles by:
ALSharqi
R
Alenzi
BY
Other links:
PubMed Citation
Related articles in PubMed
|
|
Merit Research Journal of Medicine and Medical
Sciences (ISSN: 2354-323X) Vol. 6(7) pp. 265-271,
July, 2018
Copyright © 2018 Merit Research Journals |
|
Original Research Article
The Incidence of
Neutropenia Post Kidney Transplant Patient at Prince Sultan
Military Medical City |
|
| |
| |
|
Reem ALSharqi1, Linah
ALMuhawwis2, Haddah AlKhaldi2, Abdulaziz
Alanizi1, Faris AlAbdulkareem1, Mohammed
M. Alanazi3 and Faris Q. Alenzi4,5* |
|
|
1King
Abdulaziz Medical City, Riyadh, KSA
2Prince Sultan Military Medical City, Riyadh, KSA
3Fronsic Medicine services, Riyadh, KSA
4Dar Shefa Hospital, Riyadh, KSA
5Professor of Immunology, College of Applied Medical
Sciences, Prince Sattam bin Abdulaziz University (PSAU), Al-Kharj,
Saudi Arabia
*Corresponding Authors’ E-mail: fqalenzi@ksu.edu.sa
Accepted July 15, 2018 |
|
|
Abstract |
|
|
There are
indirect evidences showed that there is an association between
neutropenia and some of the medications such as Anti-thymocyte
Globulin (ATG), Mycophenolic acid (MPA) and Tacrolimus (TAC)
that are use for kidney transplant patients. It is evidenced
that are driven upon reducing dose or holding these medications.
The prolonged and severe neutropenia can lead to serious
infections and allograft rejection. A retrospective cohort study
where patients had been tackled over six months post kidney
transplantation. The 81 patients who had transplantation between
January 2014 and December 2014 were identified and followed up
using hospital system and patients medical records. The
incidence of neutropenia was 11.11%. The findings show an
association between neutropenia post kidney transplant and some
factors including: female gender and the use of
immunosuppressant medications, like MPA (P>0.05). Eighty one
patients were tackled retrospectively for 6 months. The
incidence of neutropenia were 11.11%. TAC and MPA were used in
all of patients. This study claimed that these medications might
increase the risk of neutropenia post kidney transplant; P<0.05.
The findings of the present study indicate the holding MPA and
using G-CSF is significantly effective to accelerate the
recovery of neutropenia. The incidence of neutropenia in this
study was relatively high post kidney transplant with female
gender and MPA alone or in combination with TAC being
potentially associated factors with neutropenia.
Keywords: Neutropenia, Kidney transplant, Medication,
Immunosuppressant
|
|
|
|